
Tirzepatide (20mg)
Tirzepatide (20mg) is listed as a single-compound research material with a labelled amount of 20mg. This format is currently unavailable to order.
SKU: PEP-021-20MG
COA ✓ · 99.761%Metabolic Research
SKU: PEP-021-40MG
Tirzepatide (40mg) is listed as a single-compound research material with a labelled amount of 40mg. The single-vial catalogue price is $229.99 USD.
Quantity savings: 2–4 vials 5%, 5–9 vials 10%, 10+ vials 15%.
1 × $229.99$229.99
For laboratory research only. Not for human or veterinary use.
Tirzepatide (40mg) is listed as a single-compound research material with a labelled amount of 40mg. The single-vial catalogue price is $229.99 USD.
The amount shown refers to the vial label. Compare other formats separately, including their price and documentation.
Store and handle according to the instructions provided for the supplied lot.
| Compound | Tirzepatide |
|---|---|
| CAS Number | 2023788-19-2 |
| Molecular Formula | C225H348N48O68 |
| Molecular Weight | 4813.5 g/mol |
| Sequence | 39-residue GIP/GLP-1 dual agonist with a C20 diacid lipid side chain |
| Category | Metabolic Research |
| Reported purity | 99.761% (CoA Reported) |
| Labelled amount | 40mg |
| Form | Lyophilized Powder |
| Storage | Consult the storage guidance supplied with the specific lot. |
Published batch report available.
Match the document’s sample, lot and labelled size. The document applies to its tested sample.
In Stock. Single-vial price: $229.99 USD.
Published batch report available. View documentation above.
For each available product: 2–4 vials receive 5% off, 5–9 receive 10% off and 10 or more receive 15% off, subject to the displayed quantity limit.
40mg identifies the amount on this vial’s label. It does not describe a concentration or a personal dose.